Cyclerion Therapeutics, Inc. (NASDAQ:CYCN – Get Free Report)’s share price was up 3.5% during mid-day trading on Tuesday . The stock traded as high as $3.40 and last traded at $3.25. Approximately 66,286 shares changed hands during mid-day trading, a decline of 8% from the average daily volume of 71,822 shares. The stock had previously closed at $3.14.
Cyclerion Therapeutics Stock Down 0.3 %
The company’s fifty day moving average price is $2.89 and its 200-day moving average price is $2.86.
Cyclerion Therapeutics Company Profile
Cyclerion Therapeutics, Inc, a biopharmaceutical company, develops treatments for serious diseases. It is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to out-license for cardiovascular diseases; and Praliciguat, a systemic sGC stimulator that is licensed to Akebia Therapeutics, Inc for the treatment of rare kidney disease.
See Also
- Five stocks we like better than Cyclerion Therapeutics
- Why Invest in High-Yield Dividend Stocks?
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- What Are the FAANG Stocks and Are They Good Investments?
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- Find and Profitably Trade Stocks at 52-Week Lows
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Cyclerion Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyclerion Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
